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Transferrin Receptor 2 Dependent 
Alterations of Brain Iron 
Metabolism Affect Anxiety  
Circuits in the Mouse
Rosa Maria Pellegrino1,2,*, Enrica Boda3,4,*, Francesca Montarolo4, Martina Boero1,2, 
Mariarosa Mezzanotte1,2, Giuseppe Saglio1,2, Annalisa Buffo3,4,† & Antonella Roetto1,2,†
The Transferrin Receptor 2 (Tfr2) modulates systemic iron metabolism through the regulation of 
iron regulator Hepcidin (Hepc) and Tfr2 inactivation causes systemic iron overload. Based on data 
demonstrating Tfr2 expression in brain, we analysed Tfr2-KO mice in order to examine the molecular, 
histological and behavioural consequences of Tfr2 silencing in this tissue. Tfr2 abrogation caused an 
accumulation of iron in specific districts in the nervous tissue that was not accompanied by a brain Hepc 
response. Moreover, Tfr2-KO mice presented a selective overactivation of neurons in the limbic circuit 
and the emergence of an anxious-like behaviour. Furthermore, microglial cells showed a particular 
sensitivity to iron perturbation. We conclude that Tfr2 is a key regulator of brain iron homeostasis and 
propose a role for Tfr2 alpha in the regulation of anxiety circuits.
Body iron amount and availability is finely regulated by Hepcidin (Hepc), a peptide produced mainly by the liver, 
that acts on the cellular iron exporter Ferroportin 1 (Fpn1), causing its degradation and decreasing de facto the 
amount of serum iron1. A complex protein network is involved in hepatic Hepc regulation according to the body 
iron needs, causing Hepc decrease in iron demand conditions (anaemia, hypoxia, ineffective erythropoiesis) and, 
on the contrary, a Hepc increase when a sufficient iron amount is present in the body or during inflammatory 
processes2. Dysfunction of most Hepc regulatory proteins is responsible of hereditary disorders of iron metabolism3,4. 
Among these regulators, Transferrin receptor 2 (Tfr2) is codified by a gene whose mutations are responsible for a 
rare form of hereditary haemochromatosis named HFE35,6. The TFR2 gene is transcribed in two main isoforms, 
Tfr2 alpha and Tfr2 beta. Tfr2 alpha is highly produced in the liver and works as an iron sensor that regulates 
serum Hepc level. Accordingly, Tfr2 targeted animals show iron overload due to an inappropriately low level 
of Hepc7–9. The Tfr2 beta isoform, instead, appears to play a specific role in the regulation of iron export from 
reticulo-endothelial cells9.
In the central nervous system (CNS), iron levels need to be tightly controlled to appropriately regulate key 
functions such as neurotransmission and myelination as well as neural cell division10. Iron overload in defined 
CNS areas associates with neurodegeneration in Parkinson’s and Alzheimer’s diseases11–13, suggesting a role 
for iron overload in circuit malfunctioning and damage. Furthermore, studies in animal models in which iron 
amount was experimentally increased show an alteration of the main iron-related proteins Ferritin (Ft) and 
Transferrin Receptor 1 (Tfr1) in the brain14–16, revealing perturbation of iron brain homeostasis.
It is generally accepted that iron enters neurons10, microglial17,18 and choroid plexi cells19 bound to Tfr1 and 
it has been shown that the iron hormone Hepc is expressed in the brain20–23, similar to other Hepc regulatory 
proteins10. Yet, it is still unclear how iron levels and localization are regulated in cerebral compartments. Similarly, 
it remains to be fully understood whether the iron protein regulatory network in the CNS is the same operating 
in the rest of the body and how systemic and cerebral iron regulation are interconnected.
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Similar to other Hepc regulatory proteins, Tfr2 gene expression has been shown in total brain extracts23, in 
defined cellular compartments of specific neuronal subtypes24 and in brain tumor cell lines23,25. Furthermore, a 
transcriptome study on Tfr2 null mice revealed that several genes involved in the control of neuronal functions 
are abnormally transcribed16.
In this study we aimed to clarify Tfr2 functions in the brain by examining a mouse model in which both 
Tfr2 isoforms are inactivated (Tfr2-KO)9. To distinguish the effects of Tfr2 abrogation from those due to 
Tfr2-independent iron load modifications, we also examined WT sib pairs subjected to an iron enriched diet 
(IED) and WT or Tfr2-KO mice upon an iron deficient diet (IDD).
Results show that Tfr2 silencing determines an increased brain iron availability that associates with 
anxious-like behaviours.
Materials and Methods
Animals. Ten weeks old Tfr2-KO male mice9 maintained on 129 X 1/svJ strain were analyzed and compared 
to wild type (WT) sex and age matched sib pairs. Animal housing and all the experimental procedures were per-
formed in accordance with European (Official Journal of the European Union L276 del 20/10/2010, Vol. 53, p. 
33–80) and National Legislation (Gazzetta Ufficiale n° 61 del 14/03/2014, p. 2–68) for the protection of animals 
used for scientific purposes. Groups of 4–5 mice were housed in transparent conventional polycarbonate cages 
(Tecnoplast, Buggirate, Italy) provided with sawdust bedding, boxes/tunnels hideout as environmental enrich-
ment and striped paper as nesting material. Food and water were provided ad libitum; environmental conditions 
were 12 h/12 h light/dark cycle, room temperature 21 °C ± 1 °C and room humidity 55% ± 5%. Experimental pro-
cedure was preventively approved by the Ethical Committee of the University of Turin.
Experimental conditions. Tfr2-KO mice were fed with a standard diet (SD) (GLOBAL DIET 2018, 
Mucedola SrL, Italy, 0, 2 g iron/Kg food). Age and sex matched animals in SD were used as WT controls. 
Subgroups of mice were further kept on:
a) iron deficient diet (IDD) to induce anaemia in WT mice and to decrease iron amount in Tfr2-KO mice, by 
feeding mice with a purified diet without added iron (Mucedola SrL, Italy) starting from weaning until sacrifice 
(8 weeks of treatment);
b) iron enriched diet (IED) to trigger secondary iron overload in WT animals by feeding them with a 2% iron 
enriched standard diet from weaning until sacrifice (8 weeks of treatment).
IED was preferred to parenteral iron injection because it resembles iron overload occurring in chronic haemo-
chromatosis. Furthermore, since it has been demonstrated that an iron enriched diet for a short period of time 
does not cause changes in iron regulating proteins26, we decided to submit animals to 8 weeks of IED. On the 
other hand, IDD treatment was chosen to avoid the side-effects of acute iron deprivation obtained by extensive 
phlebotomies that, by causing inflammation, influence the Hepc pathway27,28.
At the end of the experiments, mice were given an anaesthetic overdose (see below) and sacrificed. Blood, 
brain and liver were collected for subsequent analysis.
For behavioural analyses, 8 WT and 9 Tfr2-KO naïve mice in SD were tested in the Morris water maze and 
elevated plus maze (EPM) tests. Subsequently, 19 WT and 13 Tfr2-KO naïve mice in SD, 12 WT and 17 Tfr2-KO 
naïve mice in IDD and 5 WT naïve mice in IED were tested in EPM.
A subset of Tfr2-KO and WT mice was transcardially perfused with 0.12 M phosphate buffer (PB) pH 7.2–7.4 
(50 ml, 15 min) to remove blood from brain tissue before Western Blot analysis and the measurement of brain 
iron content (see below). Perfusions were carried out under deep general anaesthesia (ketamine, 100 mg/kg; 
Ketavet, Bayern, Leverkusen, Germany; xylazine, 5 mg/kg; Rompun; Bayer, Milan, Italy).
Molecular biology analyses. Frozen dissected regions or total brains from WT mice were utilized for 
quantitative PCR while only total brain of Tfr2-KO and WT animals was used for Western Blot analysis.
Real time quantitative PCR analysis. For reverse transcription, 1 μ g of total RNA, 25 μ M random hexamers, 
and 100 U of reverse transcriptase (Applied Biosystems) were used. Gene expression levels were measured by 
real-time quantitative PCR in a CFX96 Real-Time System (BIO-RAD). For Tfr2 alpha, Tfr2 beta and BDNF, 
SYBR Green PCR technology (EVAGreen, BIO-RAD, Italy) was used utilising specific primers whose sequences 
are reported in Supplemental Informations. Gus (β -glucuronidase) gene was utilized as housekeeping control9,29. 
The results were analysed using the Δ Δ Ct method30. All analyses were carried out in triplicate; results showing a 
discrepancy greater than one cycle threshold in one of the wells were excluded.
Western Blot analysis. WB experiments were done with at least 6 animals for each experimental group. Fifty μ g 
of total brain lysates were separated on an 8–15% SDS polyacrylamide gel and immunoblotted according to stand-
ard protocols. Antibodies against the following proteins were used: Transferrin (Tf) (F-8), Tfr1 (CD71 H-300), 
Divalent Metal Transporter1 (DMT1) (H-108), Fpn1 (G-16) and β -Actin (C-4) (Santa Cruz Biotechnology); Tfr2 
alpha and Hepc (Alpha Diagnostic International). Antibodies against the two Ferritins (Ft-H and Ft-L) were 
kindly provided by Sonia Levi, University of Vita Salute, Milan, Italy. Data from WB quantification (Image Lab 
Software, BIO-RAD, Italy) were normalized on levels of β -Actin bands and expressed as fold increase relative to 
the mean value obtained from WT mice.
Liver and brain iron content. Iron concentration on livers (Liver Iron Content, LIC) and brains (Brain Iron 
Content, BIC) freshly dissected was assessed according to standard procedures9 using at least 20 mg of dried total 
tissue. For histological assessment of non-heme iron deposition, brain slices of perfused animals were stained 
with DAB-enhanced Prussian blue Perls’ staining31.
www.nature.com/scientificreports/
3Scientific RepoRts | 6:30725 | DOI: 10.1038/srep30725
Histological and immunofluorescence procedures. For histological analyses experimental animals 
were perfused with 4% paraformaldehyde in PB. Brains were removed and post-fixed for 24 h at 4 °C, cryopro-
tected in 30% sucrose in 0.12 M phosphate buffer and processed according to standard protocols32. Brains were 
cut in 30 μ m thick coronal sections collected in PBS and then stained to detect the expression of different anti-
gens: Glial fibrillary acidic protein (GFAP) (1:1000, Dakopatts); Iba1 (1:1000, Wako); cFos (1:1000, Santa Cruz 
Biotechnology); Zif-268 (1:1000, Santa Cruz Biotechnology); vGlut1 (1:1500, Synaptic System); vGlut2 (1:1500, 
Synaptic System); Tfr2 alpha (1:500, Alpha Diagnostics); hepcidin/pro-hepcidin (1:1000 with amplification with 
tyramide kit, see below, Alpha Diagnostics). Incubation with primary antibodies was made overnight at 4 °C 
in PBS with 0.5% Triton-X 100. The sections were then exposed for 2 h at room temperature (RT) to secondary 
Cy3- (Jackson ImmunoResearch Laboratories, West Grove, PA) and Alexafluor- (Molecular Probes Inc, Eugene 
Oregon) conjugated antibodies33. 4,6-diamidino-2-phenylindole (DAPI, Fluka, Milan, Italy) was used to counter-
stain cell nuclei. After processing, sections were mounted on microscope slides with Tris-glycerol supplemented 
with 10% Mowiol (Calbiochem, LaJolla, CA). For colabelling of primary antibodies developed in the same spe-
cies, the high sensitivity tyramide signal amplification kit (Perkin Elmer, Monza, Italy) was utilized according to 
the manufacturer’s instruction33. Myelin Gallyas staining was performed as documented34.
Image Processing and Data Analysis. Histological specimens were examined using an E-800 Nikon 
microscope (Nikon, Melville, NY) connected to a colour CCD Camera and a Leica TCS SP5 (Leica Microsystems, 
Wetzlar, Germany) confocal microscope. Adobe Photoshop 6.0 (Adobe Systems, San Jose, CA) was used to adjust 
image contrast and assemble the final plates. Quantitative evaluations (densitometry of staining intensities, cell 
densities) were performed on confocal images followed by Neurolucida- (MicroBrightfield, Colchester, VT) 
and ImageJ- (Research Service Branch, National Institutes of Health, Bethesda, MD; available at: http://rsb.info.
nih.gov/ij/) based analyses. For the analysis of microglia in the cerebral cortex, we routinely scanned the entire 
cortical grey matter included in slices from Bregma 1.10 mm to Bregma-2.00 mm. Analyses were performed 
on slices from Bregma-1.50 mm to Bregma-2.00 mm for the dorsal hippocampus; from Bregma-2.50 mm to 
Bregma-3.00 mm for the ventral hippocampus; from Bregma1.50 mm to Bregma 2.20 mm for the medial prefron-
tal cortex (mPFC); from Bregma-1.20 mm to Bregma-1.60 mm for the basolateral and central amygdala (BLA and 
CeA); from Bregma-0.70 mm to Bregma-1.00 mm for the hypothalamic periventricular nucleus (PVN). When 
the high density of cFos/Zif-268-positive cells impaired the easy recognition of individual nuclei (i.e., in Cornu 
Ammonis 1, CA1 and medial prefrontal Cortex, mPFC), the mean cFos/Zif-268 staining intensity (with back-
ground subtraction) over the whole area of the region of interest was evaluated. Measurements derived from at 
least 3 sections per animal. At least three animals were analysed for each experimental condition.
Behavioural tests. The Morris water maze35 and EPM36 tests were performed to evaluate learning and 
anxious-like behaviours, respectively. Data were recorded automatically from the digitized image by using a com-
puterized video tracking software. Details about the procedures can be found in Supplemental Information.
Serum Collection and Analysis. Blood samples were collected, centrifuged, and serum was frozen 
at − 20 °C until analysis. Serum was assayed for corticosterone levels by using commercially available kits 
(Corticosterone 3H RIA, MP Biomedicals, Italy). All the blood samples were collected at the same time in the 
morning to minimize the physiological variations.
Statistical analysis. Statistical analyses were carried out by GraphPad Prism (San Diego California, USA) 
or SPSS software packages (Bangalore, India, www.spss.co.in). In most cases we used Unpaired t-test or one-way 
ANOVA followed by Bonferroni’s post hoc analysis. As regards behavioural data, repeated-measures two-way 
ANOVA followed by Bonferroni’s post hoc analysis was performed to evaluate Morris water maze performances 
during days. Mann-Whitney U test was assessed to evaluate the statistical significance for Accuracy Ratio (AR) 
and path length in Morris water maze test. One-way ANOVA followed by Bonferroni’s post hoc analysis was used 
to evaluate the EPM performances. In all instances, P < 0.05 was considered as statistically significant. Data were 
expressed as averages ± standard error of the mean. Only statistically significant results vs WT and vs Tfr2-KO 
were shown in the figures while all statistically significant P and F values as well as outputs of post hoc analyses 
were included in Table 1S. Statistically not-significant results were omitted.
Results
Tfr2 alpha expression in anxiety and stress-related circuits. A transcriptional analysis on WT mice 
major brain compartments revealed that Tfr2 alpha mRNA is expressed, although less than in the liver, in all 
analysed areas, and reaches the highest level in the hippocampus (Fig. 1A).
Conversely, real time analysis, performed with primers of similar efficiency, showed a low and homogeneous 
level of Tfr2 beta mRNA expression in the same brain areas that, also in this case, was lower compared to the liver 
(Fig. 1A). Based on these data, we concluded that Tfr2 alpha is the main Tfr2 isoform in the brain and conse-
quently we focused on Tfr2 alpha for the next experiments.
Tfr2 alpha protein in total brain extracts showed a trend to decrease in WT IDD mice compared to WT mice, 
while it did not vary in WT IED animals (Fig. 1B). These data are in line with the role of Tfr2 as an iron sensor 
contributing to iron homeostasis and with previous data demonstrating that Tfr2 protein is stabilized on plasma 
membranes by iron loaded Transferrin (Fe-Tf)37.
Immunofluorescence labelling with an anti-Tfr2 alpha specific antibody showed elongated thin structures 
occurring either as tightly associated fascicles or isolated fibers (Fig. 1C,G). In grey matter nuclei, a dense punc-
tate staining was occasionally seen (Fig. 1E,F,H). Both patterns are consistent with labelling of neurites or fiber 
tracts. Interestingly, anti-Tfr2 alpha labelling was prominent in brain circuits controlling anxiety and stress38,39 
including the hippocampus (where Mossy fibers, Mf; were strongly stained, Fig. 1C,D), the amygdala (namely 
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the central nucleus, CeA; Fig. 1E) and the hypothalamic paraventricular nucleus (PVN; Fig. 1F). Scattered Tfr2 
alpha-positive (+ ) fiber-like structures were also found in the in the cerebral cortex (Fig. 1G) and in thalamic par-
aventricular and habenular nuclei (Fig. 1H). Absence of labelling in Tfr2-KO mouse brain testified the specificity 
of anti-Tfr2 alpha staining (Fig. 1C’).
Increased iron amount in Tfr2-KO brain. All mice were examined at 10 weeks of age, when tissue alter-
ations have been observed in other mouse models of iron loading40,41. Tfr2-KO showed a significant increase in 
total brain iron amount compared to WT mice (Table 1). However, this increase was attributable to circulating 
iron, since brains of Tfr2-KO mice in which blood was removed though tissue perfusion, have a BIC (Brain Iron 
Content) similar to WT (Table 1). Interestingly, aged-matched WT IED mice, despite being iron overloaded in 
Figure 1. Tfr2 alpha expression in the adult telencephalon. (A) Tfr2 alpha and beta isoforms transcription 
pattern in major brain compartments of WT SD mice. CRTX, cortex; HIP, hippocampus; CRBL, cerebellum; 
STR, striatum; transcription amount of both Tfr2 isoforms in the liver was used as comparison. Number in 
parenthesis under each column indicates the number of animals compartments analysed. The expression level 
of the two Tfr2 isoforms was normalized to levels of GUS housekeeping gene as described in the MM section. 
In order to perform a double comparison of the same genes in different brain compartments and of the two 
Tfr2 isoforms in the same compartment we normalized all data on the value of Tfr2 alpha in the cerebral 
cortex (CRTX). (B) Western blot analysis and quantification of brain Tfr2 alpha protein. Results are shown 
as averages ± standard error of the mean of 3 independent experiments. All the statistically significant results 
are reported in Table 1S. a.u. arbitrary unit; SD standard diet, IDD iron deficient diet; IED iron enriched diet. 
(C–H) Immunofluorescence localization of Tfr2 alpha in brain. In WT brains Tfr2 alpha positivity is found in 
fibers of the dentate gyrus of the hippocampus and their terminal region in the CA3/CA2 areas (D). A dense 
dotted staining is also detected in the CeA (E), PVN (F), LHb (H) and PVN (H) grey matter nuclei. Sparse axon 
fibers are labelled for Tfr2 alpha in the cerebral cortex (G). Absence of staining in Tfr2-KO mice confirms the 
antibody specificity (C’). Scale bars: 100 μ m. DG, dentate gyrus; CA, Cornus Ammonis; CeA, central nucleus 
of the amygdala; PVN, paraventricular nucleus of hypothalamus; CTX, neocortex (primary M1 motor cortex); 
LHb, lateral habenula; PVTN, paraventricular nucleus of thalamus; Mf, mossy fibers; V, ventricle.
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the liver (Table 1) and in the serum (Transferrin saturation: 49,8 ± 4.45% vs 26 ± 4.95% P < 0,05), did not display 
evidence of global iron increase in the brain. In both Tfr2-KO and WT mice in IDD, BIC decreased below con-
trols levels (Table 1).
To assess possible localised changes in iron levels or distribution, we performed histochemical analysis in PFA 
perfused brains by DAB-enhanced Prussian blue Perls’ staining. Tfr2-KO brains sections showed an increased 
number of brown positive precipitates compared to control mice (Fig. 2) in defined parenchymal regions 
such as the hippocampal CA1 and CA3 regions (Fig. 2C–F), the PVN (Fig. 2I–J’) and the striatal white matter 
(Fig. 2G,H). We also observed DAB-positive small cells, mostly resembling microglia (insets in 2G and H), that 
were more frequently detected in Tfr2-KO brains (Fig. 2A,B,I–J’). Increased iron was also highlighted by intense 
staining of both choroid plexi and ependyma in mutant mice (Fig. 2A,B,I,J). These results show that iron accumu-
lates in the nervous tissue when Tfr2 is abrogated.
Brain Hepc levels in iron overloaded Tfr2-KO mice. Since Tfr2 is a regulator of Hepc production2 in the 
liver, we asked whether its deletion also affected Hepc amount in the brain. In agreement with its role of negative 
regulator of iron availability, in liver and brain of WT mice Hepc production changed according to the different 
systemic iron amount: it decreased in animals on IDD and increased in animals on IED (Table 1, Fig. 3A). On the 
contrary, in Tfr2-KO mice, despite increased systemic and circulating iron, cerebral Hepc was significantly lower 
than in WT mice (Fig. 3A). Furthermore, while liver Hepc transcription significantly decreased in Tfr2-KO IDD 
mice (Table 1) brain Hepc transcription increased in consequence of IDD, reaching WT IDD levels (Fig. 3A) and 
suggesting a deregulated expression of Hepc in the KO brain. In order to distinguish the contribution of the cir-
culating protein to the Hepc level found in Tfr2-KO brain, Hepc quantification was repeated in brains of perfused 
animals. Despite iron accumulation in KO brains, there is no obvious dysregulation of brain-derived Hepc. These 
data are consistent with lack of overexpression of Hepc in perfused Tfr2-KO brain (Fig. 1S).
To further corroborate these data with an independent approach, we examined anti-Hepc immunostaining on 
brain slices. Consistently with previous data42, Hepc positive cells in the cerebral cortex and hippocampus mainly 
displayed neuronal morphologies (Fig. 3B,C,F,G). In these areas no relevant differences were observed in the 
Hepc expression pattern or in the densities of positive cells of WT and Tfr2-KO mice, although the latter seems to 
have a slight decrease in overall staining. Conversely, and in line with systemic Hepc regulation2, WT IED mice 
had a marked increase in the number of Hepc + cells in the cortex and in the hippocampal dentate gyrus (DG) 
(Fig. 3E–I). Surprisingly, and on the contrary to what occurs in the liver, where Hepc transcription significantly 
decreases (Table 1), the pattern and the density of brain Hepc + cells in Tfr2-KO IDD mice remains comparable 
to WT (Fig. 3B–D,F–H), confirming the result of WB analysis.
Brain iron regulatory proteins are altered in Tfr2-KO mice. Transcriptional analysis of main Hepc 
regulatory genes, Hfe and Hjv2 did not reveal significant variations in the brain of Tfr2-KO mice compared to WT 
animals (not shown). Total brain production of the Hepc target protein Fpn143, resulted to be modulated in the 
different WT experimental groups with an opposite trend compared to cerebral Hepc amount, even if results did 
not reach statistical significance (Fig. 3L). Inverse relationship between the two proteins in WT animals is further 
evidenced by a very good fitting in regression analysis, while an apparent opposite trend, despite not statistically 
different from the WT pattern, could be observed in Tfr2-KO mice (Fig. 2S).
To molecularly analyse the increased amount of intracellular iron in the brain parenchyma, we evaluated the 
three main iron proteins responsible of cellular iron storage (Ft subunits H and L) and transport (Tf). They all 
resulted modulated. While in Tfr2-KO mice brain both Ft-H and Ft-L were higher, in WT IED mice only Ft-L 
was significantly increased (Fig. 3M,N). Iron transport protein Tf was incremented in IDD mice, as expected on 
the basis of its capability to supply with iron tissues in which iron amount is decreased44,45 (Table 1). Surprisingly, 
also Tfr2-KO mice presented an overall higher Tf amount, while this was not true for WT IED mice (Fig. 3O).
Again to verify that these proteins amount was not due to blood presence in non-perfused brains, Fts and Tf 
were analysed in brain of perfused animals. Blood removal in Tfr2-KO brains seems to cause a decrease of the 
three proteins amount. While an overall increase for Fts was confirmed, Tf displayed levels similar to WT brains, 
indicating a major role of circulating Tf in measurements in non-perfused brains (Fig. 1S).
As regards the main proteins responsible of cellular iron import, no significant variations were found for Tfr1 
levels in all the experimental groups (Fig. 3P). A lower amount of DMT1 protein was instead observed in Tfr2-KO 
brains compared to WT controls (Fig. 3Q). This result supports the hypothesis that the higher iron amount 
in Tfr2-KO mouse brains triggers a decrease in DMT1 protein according to the IRE/IRP pathway45. The same 
Genotype Diet WT SD WT IDD WT IED Tfr2-KO SD Tfr2-KO IDD
BIC (μg/g dry tissue) 237.3 ± 30.8 189.8 ± 17.4°°° 240.2 ± 30.5° 317.8 ± 81.9** 175.7 ± 25.3*, °°°
BIC^ (μg/g dry tissue) 154.5 ± 18.3 ND ND 178.1 ± 21.7 ND
LIC (μg/g dry tissue) 480.2 ± 116.7 246.1 ± 34.5°°° 1099.2 ± 87.2° 1839.3 ± 448.9*** 326.2 ± 105.4°°°
 hepatic Hepc (ΔΔCt mean) 1 ± 0.152°° 0.003 ± 0.001* * * 2.78 ± 0.360***, °°° 0.424 ± 0.174** 0.002 ± 0.003***
Table 1.  Brain and liver iron amount and hepatic Hepc transcription. WT, wild type; SD, standard diet; 
IDD, iron deficient diet; IED, iron enriched diet; ND, not determined; ^, perfused brain. * significance vs WT; 
° significance vs Tfr2-KO. Only statistically significant results vs WT and Tfr2 KO are shown. All the other 
statistically significant results are reported in Table 1S.
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regulatory mechanism accounts for DMT1 increase in WT IDD mice compared to WT, as well as in Tfr2-KO IDD 
animals compared to Tfr2-KO (Fig. 3Q).
In conclusion, Tfr2 silencing associates with changes in both CNS iron import and storage proteins, in line 
with an altered cellular distribution and availability of the metal in the brain of these mice.
Tfr2-KO mice exhibit increased anxiety. Based on high expression of Tfr2 in the hippocampus and lim-
bic circuits, we examined learning abilities and anxiety in the Tfr2-KO mice by behavioural tests. In the Morris 
water maze test no differences were found between WT and Tfr2-KO mice in the initial performance (day 1) 
(Fig. 4A). Furthermore, both WT and Tfr2-KO mice were able to improve their performance across days without 
differences (Fig. 4A). In the probe trial, the mean accuracy ratio (AR) did not show any significant difference 
between WT and Tfr2-KO mice, although Tfr2-KO mice spent about 2 fold more time in the target quadrant 
compared to wild type mice (Fig. 4B). Also in swim velocity and distance there were no differences between 
WT and Tfr2-KO mice (mean velocity ± SE, WT = 23.1 ± 1.4 cm/s, Tfr2-KO = 26.4 ± 0.8 cm/s; mean travelled 
distance ± SE, WT = 1380 ± 83.9 cm, Tfr2-KO = 1582 ± 48.4 cm; Mann-Whitney U; P > 0.05). Thus, Tfr2-KO 
mice do not show impairments of hippocampal-related spatial memory tasks. However, the trend for a stronger 
preference for the probe quadrant in Tfr2-KO mice (Fig. 4B) led us to measure the path length after mice reached 
the target zone. An increased path length outside the target zone, after reaching the original location of the plat-
form, would suggest increased flexibility in an attempt to look for a new location of the platform. On the contrary, 
longer path length in the target zone would suggest persistency possibly related to increased anxiety35. Tfr2-KO 
Figure 2. Iron accumulation in Tfr2-KO mouse brain. Iron in sections of the brain of WT and Tfr2-KO 
mice (A,B) DAB-enhanced Prussian Blue staining revealed iron accumulation in the choroid plexi (Cp) and 
ependyma (arrows) of Tfr2-KO mice (B,J’) compared to WT controls (A,I’). Higher magnification analysis also 
showed increased density of brown precipitates in the CA1 and CA3 of the mutant hippocampus (E,F), striatum 
(H) and periventricular nucleus (J,J’) compared to WT tissues (C–I’). (G,H,I’,J’). Iron labelling also decorates 
small glial cells that appeared more frequent inTfr2-KO mice. This pattern was confirmed on 3 Tfr2-KO and 
WT mice. Scale bars: (A,B,I–J’): 100 um; (B–G): 50 um. CA1, Cornus Ammonis 1, CA3, Cornus Ammonis 3, 
Cp, choroid plexus, PVN, paraventricular nucleus, 3v, third ventricle.
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mice displayed a significantly longer path length in the target zone after reaching the original position occupied 
by the platform compared with their WT sib pairs (Fig. 4C,D).
Furthermore, to avoid confounding effects due to changes in mutants of innate preference for swimming in 
defined areas of the maze46, we calculated the distance travelled and the time spent in the centre zone of the pool 
versus the periphery region on the first trial of the first day, when the spatial location of the platform was com-
pletely unknown to the mice. WT and Tfr2-KO mice did not show significant differences in the percentages of 
travelled distances and time spent in the centre of the pool (mean percentage of distance travelled in centre ± SE, 
Figure 3. Hepcidin production and iron transport/storage proteins quantification in the brain. (A) 
Western blot analysis and quantification of Hepcidin (Hepc) production changes. (B–I) Immunofluorescence 
with Anti-Hepc antibody in the neocortex. Scale bars: 100 μ m. Western blot analysis and quantification of (L) 
Ferroportin (Fpn1) (M) Ferritin H (Ft-H) (N) Ferritin L (Ft-L) (O) Transferrin (Tf) (P) Transferrin receptor 1 
(Tfr1) (Q) DMT1. Results are shown as averages ± standard error of the mean. Symbols refer to a statistically 
significant difference: * P < 0.05, * * P < 0.01, * * * P < 0.001. For reasons of clarity, only statistically significant 
results vs WT and Tfr2 KO are shown in the figure. All the other statistically significant results are reported in 
Table 1S. Vertical dotted lines indicate images taken from different gels. WT, wild type; KO, Tfr2-KO;  
IDD, iron deficient diet; IED, iron enriched diet; a.u., arbitrary unit; DG, dentate gyrus; HIP, hippocampus; 
CTX, neocortex (primary M1 motor cortex).
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Figure 4. Overt anxiety-like behaviour in Tfr2-KO mice. (A,B) Performance in Morris water maze test. 
Both WT (n = 8) and Tfr2-KO (n = 9) mice improve their performance across days and during the probe trial 
without differences between genotypes. (C,D) Path length in Morris water maze test. Measures of the total 
distance (cm) covered by WT mice and Tfr2-KO mice after they reached the target zone in the probe trial.  
(C) Tfr2-KO mice showed longer path length in the target quadrant (Qt) compared to WT mice. No differences 
are found in quadrants outside the target zone (Q1, Q2, Q3). (E–G) Performance in EPM test. Tfr2-KO (n = 22) 
mice reveal anxiety levels higher than WT SD mice (n = 27). In IDD, Tfr2-KO mice (n = 17) show a rescue in 
anxious behaviors and perform similarly to WT mice (n = 12). AR, accuracy ratio; EPM, elevated plus maze; 
SD, standard diet, IDD; iron deficient diet, IED, iron enriched diet; QT target quadrant; error bars, standard 
error of the mean. Asterisks refer to statistically significant differences: * P < 0.05, * * P < 0.01, * * * P < 0.001. 
Statistically significant results are reported in Table 1S.
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WT = 7.1 ± 3.4, Tfr2-KO = 7.1 ± 2.2; mean percentage of time spent in centre ± SE, WT = 5.4 ± 2.5 cm, 
Tfr2-KO = 5.8 ± 2.0 Mann-Whitney U; P > 0.05) thus showing that both WT and Tfr2-KO mice have the same 
innate preference for swimming in distinct areas of the maze.
Finally, we further assessed anxiety in the EPM. Notably, Tfr2-KO mice showed increased anxiety as expressed 
by a dramatically low frequency of entries in the open arms of the EPM (Fig. 4E). Consistently, they spent a little 
time in the open arms of the EPM (Fig. 4F) compared with WT siblings. Also, the total number of entries was 
reduced in Tfr2-KO mice (Fig. 4G). Then, we asked whether such anxious-like behaviour depends on iron levels 
by examining mice subjected to IDD and IED. Reductions in the frequency and time spent in open arms and in 
total entries were reverted to control values by IDD in Tfr2-KO mice (Fig. 4E,F,G). Notably, neither IDD nor IED 
affected the anxious behaviour of WT mice (Fig. 4E,F). Altogether, these data show that loss of Tfr2 associated 
with iron overload promotes the occurrence of anxious behaviours.
Higher levels of activation of the anxiety circuitry in Tfr2-KO mice. The marked anxious behaviour 
in Tfr2-KO mice suggests that Tfr2 deletion in combination with iron overload might cause an abnormal activa-
tion of the anxiety system. We therefore investigated the expression pattern of cFos and Zif-268, the immediate 
early genes frequently used as markers for neuronal activity47, in brain nuclei belonging to the anxiety circuitry, 
including the hippocampus, the medial prefrontal cortex (mPFC), the basolateral (BLA), and central (CeA) amyg-
dala and the hypothalamic paraventricular nuclei (PVN). Interestingly, in the hippocampus of Tfr2-KO mice the 
two activity markers were highly upregulated in CA3 (Fig. 5A,B,L,P) and CA1 neurons (Fig. 5A,B,F,G,I,J,M,Q), 
while their expression in the dentate gyrus (DG) did not differ from that of WT mice (Fig. 3SB and not shown). 
Of note, in Tfr2-KO mice fed with IDD anti-cFos and Zif-268 staining decreased to the levels of the WT mice in 
both CA3 and CA1 subregions (Fig. 5C,H,K,L,M,P,Q). The medial prefrontal cortex (mPFC) is one of the main 
targets of the hippocampal neurons and contributes to the anxiety control and stress responses by projecting 
to the BLA and, indirectly, to the PVN39. The levels of both cFos and Zif-268 increased significantly in this area 
of Tfr2-KO mice compared to WT or Tfr2-KO IDD mice (Fig. 5N,R). Consistently, both transcription factors 
appeared significantly upregulated in the BLA of the Tfr2-KO mice (Fig. 5O,S). Furthermore, anti-cFos/Zif-268 
immunostainings did not reveal differences in activity levels of neurons included either in the PVN (Fig. 5D,E) 
and CeA (or in other areas unrelated to anxiety control) (not shown). In line with the maintenance of WT activa-
tion levels in the CeA and PVN, the corticotropin-releasing factor (CRF) immunostaining in the PVN of Tfr2-KO 
mice did not differ from that of WT mice (Fig. 4SA,B), showing that, despite being associated with a pronounced 
anxious behaviour, Tfr2 deletion does not alter CRF release into the hypothalamo-hypophyseal portal system38. 
Accordingly, we did not find differences in corticosterone levels in Tfr2-KO serum compared to WT (Fig. 4SC). 
We further tested whether the altered activity pattern of Tfr2-KO was associated with changes in levels of BDNF, a 
key-regulator of synaptic plasticity and hippocampal activity, whose alterations were associated with iron changes 
and anxiety48. However, we did not find changes of BDNF mRNA levels in hippocampus of Tfr2-KO mice com-
pared to WT animals (Fig. 4SD). Of note, IED in WT animals also triggered a response that promoted a diffuse 
and aspecific upregulation of cFos throughout most brain areas (Fig. 3S). Thus, iron alterations due to Tfr2 defi-
ciency positively and specifically modulate neuronal activation in the CA3-CA1-mPFC-BLA circuitry, while they 
do not alter the neuroendocrine compartment implicated in anxiety regulation.
Given the high levels of expression of Tfr2 alpha in the Mossy fiber pathway, we further hypothesized that the 
activation of the anxiety circuitry were triggered by altered signals conveyed by Mf to CA3 neurons. Therefore, we 
investigated possible changes in the density of glutamatergic vGlut1/2+ terminals in CA3. While no difference 
was observed in the number of VGlut1+ puncta, the density of anti-VGlut2 positivity significantly increased at 
this site, suggesting incremented excitation and terminal remodelling (Fig. 5T,U,V). Collectively, these data are 
consistent with a role of Tfr2 alpha in the regulation of both the Mf output and the activity of the anxiety system.
Increased microglia reactivity, dystrophic changes and death in Tfr2-KO mice. Recent findings 
indicate that microglia alterations are frequently associated with increased stress and anxiety49. Although immu-
nohistological analyses did not reveal alterations of the gross anatomy of the Tfr2-KO mouse brain (Fig. 5S), 
in Tfr2-KO we found a decrease in the density of microglial cells identified by labelling for the ionized 
calcium-binding adaptor molecule 1 (Iba1), (Fig. 6A,B). This decrease occurred throughout the brain and was 
quantified in Tfr2-KO mouse cerebral cortex (Fig. 6A,B,F) and hippocampus (Fig. 6G,H).
Here, the density of both reactive (i.e showing hypertrophy and very thick short processes Fig. 6C) or degen-
erating (i.e. bearing fragmented or dystrophic processes and a pyknotic nucleus; Fig. 6D–E’) Iba1+ cells appeared 
significantly increased compared to WT mice (Fig. 6G,H), suggesting that reactive and degenerative events occur 
in parallel and that the latter changes dominate, thereby resulting in the reduction of the microglial pool in the 
Tfr2-KO mice.
In order to understand the correlation of the Tfr2-KO microglial phenotype with iron overload and/or anxiety, 
we looked at microglia in Tfr2-KO IDD and WT IED mice. Despite recovering a physiological density of Iba1+ 
cells in the cerebral cortex, (Fig. 6F), KO IDD mice still displayed some microglia activation and degeneration in 
the examined areas (Fig. 6G,H). Low iron levels in these mice (Table 1) indicated that such microglial alterations 
might not be due to iron overload per se. Yet, the decrease in microglial density could be a factor participating in 
the behavioural abnormalities found in Tfr2-KO mice. However, in WT IED animals microglia are also dimin-
ished in the absence of anxiety signs (Fig. 6F). Moreover, microglial reactivity and degeneration occurred in both 
Tfr2-KO IDD (Fig. 5) and WT IED mice (Fig. 6S) in the absence of an anxious phenotype, indicating that these 
features are also not directly linked to anxiety. Interestingly, we found signs of ongoing inflammation (as moni-
tored by levels of the Serum Amyloid A1 (SAA1) acute phase protein50; Fig. 7S) in the brain of WT IED mice but 
not in those of Tfr2-KO animals, suggesting that Tfr2 may be implicated in the regulation of the inflammatory 
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Figure 5. Activity-related immediate early genes in anxiety circuits. The immediate early genes cFos (A–H) 
and Zif-268 (I–K) are upregulated in neurons of the CA1 (F,G) and CA3 (A,B) areas of Tfr2-KO mice compared 
to WT brains, while no increase in positive cells occurs in the PVN (D,E). Quantifications of the number 
of positive nuclei over the area of the corresponding layers show that cFos+ or Zif-268+ cells significantly 
increased in mutant mice in standard conditions while they return to control levels in mutant fed with IDD 
diet (H,K,L,M,P,Q). This very same trend is found in the mPFC and BLA (N,O,R,S). (T–V) Quantifications 
of glutamatergic terminals in CA3 (red in (U,V)) show that vGlut2+ puncta are higher in number in Tfr2-KO 
mice, while vGlut1+ ones do not differ from WT. Asterisks refer to statistically significant differences:  
* P < 0.05, * * P < 0.01, * * * P < 0.001. Scale bars: 100 μ m, IDD, iron deficient diet; IED, iron enriched diet; PVN, 
periventricular hypothalamic nucleus; mPFC, medial prefrontal cortex; BLA, basolateral amygdala; error bars, 
standard error of the mean. Statistically significant results are reported in Table 1S.
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profile of these cells. Thus, microglia appear to strongly respond to alteration of iron metabolism but they do not 
play a specific role in the behavioural alterations of Tfr2-KO.
Discussion
In this work we show that Tfr2 germinal silencing affects brain iron homeostasis. Furthermore, we reveal that 
Tfr2 alpha is highly expressed in neurites of brain circuits of anxiety and stress disorders. This pattern, together 
with the prominent anxious behaviour of Tfr2-KO mice, strongly suggests a role for Tfr2 alpha in the regulation 
of anxiety circuits. Finally, our results further highlight a particular sensitivity of microglia to perturbations of 
iron metabolism, even when peripheral iron accumulation is moderate and does not associate with behavioural 
alterations.
Tfr2 alpha is the mainly transcribed isoform of the TFR2 gene, whose mutations are responsible of a form of 
hereditary hemochromatosis named HFE36. Hereditary haemochromatosis is a genetically heterogeneous disease 
due to functional impairment of the iron hormone Hepc and of several Hepc regulating proteins3.
Tfr2 alpha is a key iron sensor that, in liver, triggers a signal transduction cascade that activates the expression 
of Hepc, a small protein that reduces iron efflux from cells and leads to its intracellular accumulation2. Tfr2 beta 
isoform is instead known to exert a role in iron efflux in spleen reticuloendothelial cells9. So far, several papers 
reported a Tfr2 alpha expression in the nervous tissue23–25 that was proposed to be restricted to specific brain 
regions23,24. Our transcriptional and immunohistological analyses validated in Tfr2-KO mice, showed relevant 
Tfr2 alpha expression in the nervous tissue and revealed Tfr2 alpha protein distribution in the neurite compart-
ment of limbic areas implicated in anxiety and stress response. This expression pattern is not fully consistent with 
those previously reported in human tissues23, that described Tfr2 expression only in the cerebellum. While this 
discrepancy may be due to species-specific factors, open access transcriptome data published on GEO Profiles 
indicate that in both humans and rodents Tfr2 is not exclusively expressed in the cerebellum and is detected in 
hippocampus, cerebral cortex, basal ganglia and amygdala (Profile: GDS2678/40311_at/, Brain regions of humans 
and chimpanzees; Profile: GDS1406/160674_at/Tfr2, Brain regions of various inbred strains). Further, a low and 
ubiquitous Tfr2 alpha expression in mouse neural cells and brain endothelium below the sensitivity of the detec-
tion approach applied in this study may occur. Indeed, the diffuse upregulation of Hepc in WT IED brains sup-
ports the presence of a more widespread Tfr2 alpha expression.
Figure 6. Microglial phenotypes in Tfr2-KO and WT mice. Immunofluorescence (A–E’) and quantification 
(F) of microglial cells using Iba1 marker in total brain. Quantification of reactive (G) and degenerating (H) cells 
in cortex (Ctx) and hippocampus (Hip). Arrowheads indicate Iba1+ microglia density (A,B). Arrows indicate 
reactive morphologies (C), signs of degeneration (yellow arrows, D’) and pyknosis (arrows in (E), E’). Asterisks 
refer to statistically significant differences: * P < 0.05, * * P < 0.01. Statistically significant results are reported in 
Table 1S. CTX, neocortex (primary M1 motor cortex); HIP, hippocampus; IDD, iron deficient diet; IED, iron 
enriched diet; error bars, standard error of the mean. D’, E’, single optical slices. Scale bars: 20 μ m.
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Based on the key role of Tfr2 in regulating liver iron load, one obvious expectation was to find an increased 
iron amount in the parenchymal nervous tissue upon Tfr2 deletion. Indeed, in total brain extracts of Tfr2-KO 
including circulating blood, BIC was significantly higher than that of both WT and WT IED, underscoring that 
in these animals brain parenchyma is exposed to a higher iron amount. Moreover, Perls’ staining on brains from 
Tfr2-KO perfused mice revealed that iron accumulates in some of the brain regions where we found relevant Tfr2 
expression (hippocampal CA1 and CA3, PVN) as well as in compartments, such as the choroid plexi, which are 
sites of iron trafficking between systemic circulation and the brain environment51.
Yet, despite iron deposition, no changes in Hepc protein levels were observed in the nervous tissue, as detected 
by WB and immunofluorescence. Thus, the strong Hepc reduction in samples containing circulating blood 
reflects essentially peripheral/systemic Hepc blunting in the absence of Tfr2.
In line with an increased iron amount in Tfr2-KO brain, levels of the iron storage protein ferritin globally 
increase. Ferritin H subunit in particular, is specifically increased in Tfr2-KO mice. This induction may reflect 
the need to counteract the deleterious effects of an enhanced iron-based Fenton reaction, which produces dam-
aging hydroxyl radicals52. Tf protein is overexpressed in both WT IDD and Tfr2-KO IDD brain, as expected in 
condition of iron deprivation44,45. Unexpectedly Tf displays an increase, although not statistically significant, also 
in Tfr2-KO brains from non-perfused mice, while it is comparable to WT levels in brains from perfused animals. 
These results are consistent with the additional presence of blood Tf in non-perfused brains.
There is a tendency to decrease for the iron importer DMT1 in Tfr2-KO brains, in agreement with a higher 
iron content, at least in defined cell type(s) of the brain tissue. Moreover, its increase both in Tfr2-KO IDD and 
in WT IDD mice brain is a correct response to iron deprivation based on the activation of the intracellular iron 
regulatory IRE/IRP response system45. Overall these alterations are consistent with a Tfr2 alpha-dependent dys-
functional iron handling in the brain, even though we cannot exclude that over time an exacerbation of the iron 
burden in WT IED animals could eventually lead to a phenotype overlapping that of Tfr2-KO mice.
From the behavioural point of view, iron increase in Tfr2-KO mice was accompanied by anxious-like behav-
iour as assessed by the EPM, where Tfr2-KO SD mice spent proportionally less time in the anxiogenic arm com-
pared to other genotypes and conditions. Anxiety-like behaviours were dependent on iron increase, because they 
were reverted by IDD in Tfr2-KO mice. Despite in this study we cannot definitively dissect the contribution of 
systemic vs. parenchymal iron overload to the anxious phenotype, lack of anxiety signs in WT IED mice that are 
systemically overloaded but with normal brain iron content - as notably detected without perfusion to wash away 
the contaminating blood-, suggests that increased parenchymal iron deposits play a prominent role in promoting 
behavioural alterations. However, the lower systemic iron load in WT IED mice compared to Tfr2-KO mice may 
take part in the absence of the phenotype. In former studies both iron deficiency and iron overload during critical 
developmental windows or at adult ages have been shown to affect emotional behaviour in rodents53. However, 
the biological mechanisms mediating the effect of iron level alterations at early or mature stages are likely to be 
distinct. While precocious actions are plausible to rely on abnormal circuit formation, here we find changes of 
circuit activity, possibly accompanied by some degree of remodelling (see below). In line with our findings, a 
former study on the effects of experimental brain iron overload (i.p. injections of 3 mg/kg of ferrous sulphate 
for 5 consecutive days) also reported anxiety in rats, though in association with defects in spatial learning54. 
Moreover, iron-deficiency was also shown to lead to anxiety in mutant mice, likely due to the iron requirement 
in the synthesis of serotonin and noradrenaline48. Since WT IDD mice in this study did not show a brain-specific 
iron decrease, they are not expected to show behavioural alterations associated with brain iron deficiency. Finally, 
no data are known about brain iron metabolism in the few HFE3 iron overloaded patients available and no sign of 
neurological alterations has been evidenced so far. Nevertheless, it must be taken into account that these patients 
nowadays undergo early diagnosis and efficient phlebotomy until serum iron parameters normalization.
Consistent with behavioural data, in Tfr2-KO mice we found a specific and selective overactivation of the 
limbic circuits controlling anxiety and stress responses, as demonstrated by increased expression of cFos and 
Zif-268 (Fig. 8S). Surprisingly, also IED in WT mice promoted cFos/Zif-268 upregulation in the brain, but that 
was far more broad and intense compared to Tfr2-KO animals, suggesting that distinct mechanisms account for 
the induction in the two experimental models. These data provide in-depth explanation to former hints indi-
cating that alterations of iron homeostasis affect expression of neurotransmitters and trophic factors15,16,26,48,53. 
Importantly, in Tfr2-KO cFos/Zif-268 upregulation declined in IDD, thereby showing dependence on iron levels. 
Notably, in Tfr2-KO mice all the limbic stations displayed enhanced activity, with the exception of areas belong-
ing to the neuroendocrine stress axis, whose functioning appears unaffected as shown by absence of alterations 
in PVN CRF and blood corticosterone (Fig. 4S). Moreover, we report an increased V-Glut2 positivity compared 
to control levels in the CA3 Mf terminal field suggesting that Tfr2 deletion may affect the final output of the Mf 
pathway by inducing terminal remodeling or promoting immature traits in these fibers, in line with restriction of 
V-Glut2 during immature developmental stages55. Several studies have shown a positive correlation between Mf 
sprouting and increased anxiety-like behaviour in rodents56–59, suggesting that the Mf system may contribute to 
modulation of anxiety-like responses. Thus, collectively data are consistent with a model where Tfr2-dependent 
alterations in iron homeostasis affect the activity of the main brain areas responsible for the neural control of 
emotional behaviour, and promote anxiety. Further, high Tfr2 alpha expression along Mf and in nuclei of the 
limbic circuit suggests a specific role for this isoform in the regulation of the anxiety circuits.
It is interesting to note that activity alterations and behavioural abnormalities in Tfr2-KO mice are not due to 
degenerative events in neurons or astrocytes. We found degeneration only in microglia, that also display increased 
iron storage in KO mice, as detected by Perls’ staining. This suggests that iron-mediated challenge may be com-
pensated in other neural cells. Yet, microglial loss and alterations were also found in WT IED brains that did not 
show behavioural alterations, ruling out their role in the detected anxious-like traits. Nevertheless, microglial 
cells were clearly affected in the Tfr2-KO mice and displayed reactivity, dystrophic changes and death. These find-
ings are in line with their known action as buffering elements that counteract disturbances in iron regulation60. 
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However, in our study, microglial alterations are detected not only in Tfr2-KO SD but also in WT IED mice, 
thereby excluding their specific dependence on Tfr2 abrogation and supporting the hypothesis that either the 
altered or increased iron processing is responsible for the observed dystrophic modifications and degeneration 
in microglia.
Taken together, these data add to the growing body of evidence that alterations of systemic iron loading affect 
brain homeostasis and functioning, and reveal a specific role for Tfr2-dependent iron overload in the control of 
iron regulatory network in the brain tissue as well as in the control of anxious behaviours.
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